Dental Care Clinics in Delran, NJ Accepting Medicare
3 Dental Care Clinics found. Showing 1 - 3
 Brighter Dental Care (delran) Dentist Medicare: Not Enrolled in Medicare Practice Location: 1320b Fairview Blvd, Delran, NJ 08075 Phone: 856-764-2200 Fax: 856-764-2202 |
Three Little Birds Pediatric Dentistry. Tlb Pd Llc Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 3104 Bridgeboro Rd Ste A, Delran, NJ 08075 Phone: 856-444-5437 Fax: 856-314-5437 |
Brighter Dental Care (delran) Dentist Medicare: Not Enrolled in Medicare Practice Location: 1320b Fairview Blvd, Delran, NJ 08075 Phone: 856-764-2200 |
News Archive
Secretary of State Kerry warns of budget sequestration's consequences for humanitarian aid, global health in letter to Senator
"The State Department will have to stop humanitarian aid to millions of people, cut foreign assistance to Israel, and delay efforts to ramp up diplomatic security abroad after the Sept. 11 attack in Benghazi if [budget] sequestration goes into effect next month, according to Secretary of State John Kerry," Foreign Policy's "The Cable" blog reports.
Massachusetts Department of Public Health grants WDL to Pharmarama
Pharmarama, a leader in the strategic sourcing of comparator drugs for global clinical trials, today announced that the Massachusetts Department of Public Health has granted the company a Wholesale Distributor's License (WDL). The license enables Pharmarama to operate its pharmaceutical cold-chain and ambient storage and distribution facility in suburban Boston to provide extensive sourcing and comparator product storage services for its clients.
Drinking fruit juice in early years associated with healthier dietary patterns later
A new study from Boston University published on-line at BMC Nutrition by Lynn L. Moore and colleagues, found that drinking 100% fruit juice early in life was associated with healthier dietary patterns in later childhood without adversely impacting weight gain.
Study comparing subcutaneous, intravenous administration of VELCADE in relapsed MM patients presented at ASH
Millennium: The Takeda Oncology Company today reported results from a randomized, international Phase III clinical trial comparing subcutaneous and intravenous administration of VELCADE (bortezomib) in patients with relapsed multiple myeloma. These data were presented at the 52nd annual meeting of the American Society of Hematology, held December 4-7 in Orlando, Florida.
› Verified 1 days ago